JEDNOHODINOVÁ VENTILACE S POZITIVNÍM TLAKEM PO ZKOUŠCE SPONTÁNNÍHO DÝCHÁNÍ S TLAKOVOU PODPOROU: RANDOMIZOVANÁ KLINICKÁ STUDIE
This is a randomized, open, multicenter, pragmatic, adaptive clinical trial with intention-to-treat analysis. The study will compare two weaning strategies from mechanical ventilation in critically ill patients admitted to intensive care units, with more than 72 hours of mechanical ventilation and with a successful spontaneous breathing trial on pressure support. Immediately after a successful spontaneous breathing trial, eligible patients will be randomized into 2 groups that will be treated according to one of the following interventions:1) One-hour positive pressure ventilation: as soon as the success of the spontaneous breathing trial is confirmed, the patient is submitted to mechanical ventilation for 1 hour using the previous ventilatory parameters and, afterwards, extubated.2) Immediate extubation: the patient is extubated immediately after the success of the spontaneous breathing trial.
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
Detailní popis
Adaptive design for sample size. The study will include up to a maximum of 4.000 patients. First interim analysis will be performed after complete data is available for the first 500 eligible patients. The Bayesian logistic regression model will be adjusted to provide posterior probabilities that will be compared with threshold values to evaluate stopping decisions. Extensive simulations were conducted to develop and understand adaptive design performance, interim analysis timing, and decision criteria. The trial may be stopped early for efficacy or futility. Secondary outcomes will be analyzed with a gatekeeping procedure to preserve overall type I error at 0.05. Thus, the assessment of statistical significance of secondary outcomes will be performed only if the preceding outcome in the hierarchy met the threshold for statistical significance. No adjustment for multiple comparisons will be applied for analyses of tertiary outcomes and subgroups. Thus, these results should be interpreted as exploratory.Secondary outcomes tested in hierarchical order will be: (1) Mechanical ventilation free days within 28 days; (2) Hospital free days within 28 days; (3) Mortality within 28 days.
Typ studie
Typ studie
Zápis (Odhadovaný)
Zápis
Fáze
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
Studijní kontakt
- Jméno: Aline B Pereira
- Telefonní číslo: +55 (47) 99181-8400
- E-mail: linibp@hotmail.com
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Patients aged > 18 years.
- Admitted to the intensive care unit (surgical or medical).
- With endotracheal intubation.
- Mechanical ventilation for more than 72 hours.
- Who underwent successful spontaneous breathing trial (according to the study protocol) and is considered able to be extubated.
Exclusion Criteria:
- Patients unable to obey commands.
- With non-planned extubation.
- Neuromuscular disease and cervical spinal cord injury.
- Tracheostomy.
- Contraindication for cardiopulmonary resuscitation or reintubation.
- Terminal extubation.
- Lack of informed consent.
- Previously included in the trial.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Počet zbraní
Zbraně a zásahy
Skupina účastníků / ArmSkupina účastníků / Arm |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
Experimentální: Jednohodinová ventilace s pozitivním tlakem
|
As soon as the success of the spontaneous breathing trial is confirmed, the patient will be submitted to one-hour positive pressure ventilation using the previous ventilatory parameters and, afterwards, extubated. |
|
Aktivní komparátor: Okamžitá extubace
|
The patient will be extubated immediately (up to 10 minutes) after the success of the spontaneous breathing trial. |
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Number of Participants With Extubation Failure Within 7 Days
Časové okno: 7 days (from randomization through Day 7 after randomization)
|
Extubation failure is defined as a composite endpoint of reintubation or death within 7 days after randomization |
7 days (from randomization through Day 7 after randomization)
|
Sekundární výstupní opatření
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Ventilator-Free Days Through Day 28
Časové okno: 28 days (from randomization through Day 28 after randomization)
|
Ventilator-free days are defined as the number of days alive and free from invasive mechanical ventilation from randomization through Day 28 after randomization. If a patient dies before day 28, the ventilator-free days will be counted as zero. If a patient is reintubated and returns to mechanical ventilation and later is extubated again and remains in unassisted breathing until day 28, the ventilator-free days will be counted from the end of the last period of assisted breathing until day 28. An invasive mechanical ventilation period of less than 24 hours for surgical purposes will count as 1 ventilator-free day. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from mechanical ventilation for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome. |
28 days (from randomization through Day 28 after randomization)
|
|
Hospital-Free Days Through Day 28
Časové okno: 28 days (from randomization through Day 28 after randomization)
|
Hospital-free days are defined as the number of days alive and out of the hospital from randomization through Day 28 after randomization. If a patient dies before day 28, the hospital-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from hospital for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed through day 28 to ascertain this outcome. |
28 days (from randomization through Day 28 after randomization)
|
|
Number of Participants Who Died Within 28 Days
Časové okno: 28 days (from randomization through Day 28 after randomization)
|
All-cause mortality from randomization through day 28 |
28 days (from randomization through Day 28 after randomization)
|
Další výstupní opatření
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Ventilatory Support-Free Days Through Day 28
Časové okno: 28 days (from randomization through Day 28 after randomization)
|
Ventilatory support-free days are defined as the number of days alive and free from any ventilatory support (invasive or noninvasive) from randomization through day 28. Any use of invasive mechanical ventilation for any duration during a calendar day will count as 1 day with ventilatory support (i.e., not free). Use of noninvasive ventilatory support (noninvasive ventilation or high-flow nasal cannula) for ≥6 hours in any calendar day will count as 1 day with ventilatory support. Participants who die before day 28 will be assigned 0 ventilatory support-free days. If reintubation occurs and the participant later achieves unassisted spontaneous breathing again, ventilatory support-free days will be counted from the end of the last assisted-breathing period through day 28, provided the participant remains alive and free from ventilatory support. |
28 days (from randomization through Day 28 after randomization)
|
|
Number of Participants With Extubation Failure Within 2 Days
Časové okno: 2 days (from randomization through Day 2 after randomization)
|
Extubation failure is defined as a composite endpoint of reintubation or death within 2 days after randomization |
2 days (from randomization through Day 2 after randomization)
|
|
Number of Participants With Death or Reintubation Within 28 Days
Časové okno: 28 days (from randomization through Day 28 after randomization)
|
Composite endpoint of reintubation or death within 28 days after randomization |
28 days (from randomization through Day 28 after randomization)
|
|
Intensive Care Unit-Free Days Through Day 28
Časové okno: 28 days (from randomization through Day 28 after randomization)
|
ICU-free days are defined as the number of days alive and out of the intensive care unit from randomization through day 28. If a patient dies before day 28, the ICU-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered as alive and free from ICU for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome. |
28 days (from randomization through Day 28 after randomization)
|
|
Number of Participants Who Died in the Hospital
Časové okno: From randomization to hospital discharge, up to 90 days
|
All-cause mortality occurring from randomization until hospital discharge (death before hospital discharge) |
From randomization to hospital discharge, up to 90 days
|
|
Number of Participants Who Died in the Intensive Care Unit
Časové okno: From randomization to ICU discharge, up to 90 days
|
All-cause mortality occurring from randomization until ICU discharge (death before ICU discharge) |
From randomization to ICU discharge, up to 90 days
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Začátek studia
Primární dokončení (Odhadovaný)
Primární dokončení
Dokončení studie (Odhadovaný)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
Další identifikační čísla studie
- GS-Wean: PSV SBT
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .